1-[1-iodo-3-(1-phenacylazetidin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]propan-1-one;methane;1-[1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(1-phenacylazetidin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]propan-1-one;1-methyl-3-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole

C71H84BIN16O6 — CID 158805356

IUPAC1-[1-iodo-3-(1-phenacylazetidin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]propan-1-one;methane;1-[1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(1-phenacylazetidin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]propan-1-one;1-methyl-3-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole
SMILESC.CCC(=O)N1CCn2c(C3CN(CC(=O)c4ccccc4)C3)nc(-c3ccc4c(c3)c(-c3cnn(C)c3)nn4C)c2C1.CCC(=O)N1CCn2c(C3CN(CC(=O)c4ccccc4)C3)nc(I)c2C1.Cn1cc(-c2nn(C)c3ccc(B4OC(C)(C)C(C)(C)O4)cc23)cn1
InChIInChI=1S/C32H34N8O2.C20H23IN4O2.C18H23BN4O2.CH4/c1-4-29(42)39-12-13-40-27(19-39)31(34-32(40)24-17-38(18-24)20-28(41)21-8-6-5-7-9-21)22-10-11-26-25(14-22)30(35-37(26)3)23-15-33-36(2)16-23;1-2-18(27)24-8-9-25-16(12-24)19(21)22-20(25)15-10-23(11-15)13-17(26)14-6-4-3-5-7-14;1-17(2)18(3,4)25-19(24-17)13-7-8-15-14(9-13)16(21-23(15)6)12-10-20-22(5)11-12;/h5-11,14-16,24H,4,12-13,17-20H2,1-3H3;3-7,15H,2,8-13H2,1H3;7-11H,1-6H3;1H4
InChIKeyITZUIXZLOCEGRS-UHFFFAOYSA-N
MW1395.27 g/mol
LogP9.30
Rot. Bonds14

About 1-[1-iodo-3-(1-phenacylazetidin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]propan-1-one;methane;1-[1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(1-phenacylazetidin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]propan-1-one;1-methyl-3-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole

1-[1-iodo-3-(1-phenacylazetidin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]propan-1-one;methane;1-[1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(1-phenacylazetidin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]propan-1-one;1-methyl-3-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole (PubChem CID 158805356) has the molecular formula C71H84BIN16O6 and a molecular weight of 1395.27 g/mol. Its IUPAC name is 1-[1-iodo-3-(1-phenacylazetidin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]propan-1-one;methane;1-[1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(1-phenacylazetidin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]propan-1-one;1-methyl-3-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole.

Molecular Properties

Compound Name1-[1-iodo-3-(1-phenacylazetidin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]propan-1-one;methane;1-[1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(1-phenacylazetidin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]propan-1-one;1-methyl-3-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole
PubChem CID158805356
Molecular FormulaC71H84BIN16O6
Molecular Weight1395.27 g/mol
Exact Mass1394.59
IUPAC Name1-[1-iodo-3-(1-phenacylazetidin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]propan-1-one;methane;1-[1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(1-phenacylazetidin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]propan-1-one;1-methyl-3-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole
SMILESC.CCC(=O)N1CCn2c(C3CN(CC(=O)c4ccccc4)C3)nc(-c3ccc4c(c3)c(-c3cnn(C)c3)nn4C)c2C1.CCC(=O)N1CCn2c(C3CN(CC(=O)c4ccccc4)C3)nc(I)c2C1.Cn1cc(-c2nn(C)c3ccc(B4OC(C)(C)C(C)(C)O4)cc23)cn1
InChIInChI=1S/C32H34N8O2.C20H23IN4O2.C18H23BN4O2.CH4/c1-4-29(42)39-12-13-40-27(19-39)31(34-32(40)24-17-38(18-24)20-28(41)21-8-6-5-7-9-21)22-10-11-26-25(14-22)30(35-37(26)3)23-15-33-36(2)16-23;1-2-18(27)24-8-9-25-16(12-24)19(21)22-20(25)15-10-23(11-15)13-17(26)14-6-4-3-5-7-14;1-17(2)18(3,4)25-19(24-17)13-7-8-15-14(9-13)16(21-23(15)6)12-10-20-22(5)11-12;/h5-11,14-16,24H,4,12-13,17-20H2,1-3H3;3-7,15H,2,8-13H2,1H3;7-11H,1-6H3;1H4
InChIKeyITZUIXZLOCEGRS-UHFFFAOYSA-N
XLogP9.30
TPSA206.62 Ų
H-Bond Donors
H-Bond Acceptors20
Rotatable Bonds14
Heavy Atoms95
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001395.27
LogP ≤ 59.30
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1020

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'iodine', 'substructure': 'N/A'}

Analyze 1-[1-iodo-3-(1-phenacylazetidin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]propan-1-one;methane;1-[1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(1-phenacylazetidin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]propan-1-one;1-methyl-3-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-[1-iodo-3-(1-phenacylazetidin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]propan-1-one;methane;1-[1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(1-phenacylazetidin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]propan-1-one;1-methyl-3-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole?
The IUPAC name of 1-[1-iodo-3-(1-phenacylazetidin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]propan-1-one;methane;1-[1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(1-phenacylazetidin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]propan-1-one;1-methyl-3-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole (CID 158805356) is 1-[1-iodo-3-(1-phenacylazetidin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]propan-1-one;methane;1-[1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(1-phenacylazetidin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]propan-1-one;1-methyl-3-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole.
What is the SMILES notation for 1-[1-iodo-3-(1-phenacylazetidin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]propan-1-one;methane;1-[1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(1-phenacylazetidin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]propan-1-one;1-methyl-3-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole?
The canonical SMILES for 1-[1-iodo-3-(1-phenacylazetidin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]propan-1-one;methane;1-[1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(1-phenacylazetidin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]propan-1-one;1-methyl-3-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole is C.CCC(=O)N1CCn2c(C3CN(CC(=O)c4ccccc4)C3)nc(-c3ccc4c(c3)c(-c3cnn(C)c3)nn4C)c2C1.CCC(=O)N1CCn2c(C3CN(CC(=O)c4ccccc4)C3)nc(I)c2C1.Cn1cc(-c2nn(C)c3ccc(B4OC(C)(C)C(C)(C)O4)cc23)cn1.
What is the InChIKey of 1-[1-iodo-3-(1-phenacylazetidin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]propan-1-one;methane;1-[1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(1-phenacylazetidin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]propan-1-one;1-methyl-3-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole?
The InChIKey is ITZUIXZLOCEGRS-UHFFFAOYSA-N. The full InChI is InChI=1S/C32H34N8O2.C20H23IN4O2.C18H23BN4O2.CH4/c1-4-29(42)39-12-13-40-27(19-39)31(34-32(40)24-17-38(18-24)20-28(41)21-8-6-5-7-9-21)22-10-11-26-25(14-22)30(35-37(26)3)23-15-33-36(2)16-23;1-2-18(27)24-8-9-25-16(12-24)19(21)22-20(25)15-10-23(11-15)13-17(26)14-6-4-3-5-7-14;1-17(2)18(3,4)25-19(24-17)13-7-8-15-14(9-13)16(21-23(15)6)12-10-20-22(5)11-12;/h5-11,14-16,24H,4,12-13,17-20H2,1-3H3;3-7,15H,2,8-13H2,1H3;7-11H,1-6H3;1H4.
What are the key properties of 1-[1-iodo-3-(1-phenacylazetidin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]propan-1-one;methane;1-[1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(1-phenacylazetidin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]propan-1-one;1-methyl-3-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole?
1-[1-iodo-3-(1-phenacylazetidin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]propan-1-one;methane;1-[1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(1-phenacylazetidin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]propan-1-one;1-methyl-3-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole has a molecular weight of 1395.27 g/mol, XLogP of 9.30, 14 rotatable bonds, 0 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[1-iodo-3-(1-phenacylazetidin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]propan-1-one;methane;1-[1-[1-methyl-3-(1-methylpyrazol-4-yl)indazol-5-yl]-3-(1-phenacylazetidin-3-yl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl]propan-1-one;1-methyl-3-(1-methylpyrazol-4-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole is sourced from PubChem (CID 158805356), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).